Ascendis Pharma (ASND) PT Raised to $162 at TD Cowen; 'Yorvipath Off to Solid Launch'
Tweet Send to a Friend
TD Cowen analyst Yaron Werber raised the price target on Ascendis Pharma (NASDAQ: ASND) to $162.00 (from $153.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
